SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-172782
Filing Date
2024-07-01
Accepted
2024-07-01 08:33:00
Documents
18
Period of Report
2024-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d862441d8k.htm   iXBRL 8-K 35816
2 EX-10.1 d862441dex101.htm EX-10.1 99419
3 EX-10.2 d862441dex102.htm EX-10.2 29028
4 EX-10.3 d862441dex103.htm EX-10.3 29534
5 EX-10.4 d862441dex104.htm EX-10.4 71843
9 GRAPHIC g862441dsp0020.jpg GRAPHIC 5471
  Complete submission text file 0001193125-24-172782.txt   455831

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mrus-20240630.xsd EX-101.SCH 2840
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20240630_lab.xml EX-101.LAB 17166
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20240630_pre.xml EX-101.PRE 10781
20 EXTRACTED XBRL INSTANCE DOCUMENT d862441d8k_htm.xml XML 3568
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37773 | Film No.: 241088298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)